Noted Journalist Alan Duke Interviews Innovative Cancer Scientist Dr. Craig Dionne
Comparisons Drawn to Several Industry Icons
LOS ANGELES, April 22, 2015 /PRNewswire/ -- "Everybody is affected by cancer sooner or later," Dr. Dionne says. "What we do to patients is frankly brutal. We've got to get away from that." In Alan Duke's new article profiling Dr. Craig Dionne the renowned cancer scientist talks about his development of a promising new organic "out-of-box" drug that is proving to be effective and safe for killing cancerous tumors in liver, kidney and brain cancer patients with no side effects. This new drug treatment acts like a grenade because its toxic chemical is released from its wrapping only when it makes contact with a specific molecule in the blood vessels feeding tumors. Results from Phase II of this new drug treatment are showing promising results, GenSpera (www.genspera.com) is planning phase three testing for 2016, which could put mipsagargin on track for FDA approval for widespread use in 2018. "Cancer can't escape OUR drug. There is no way to get around it," Dionne says.
In Alan Duke's new interview with Dr. Dionne he compares his accomplishments in cancer research, passion for finding a cure, and his creative innovative approach on par with other technological innovators – including Elon Musk, Jeff Bezos and Larry Page.
Alan Duke's article on Dr. Dionne is available free of charge to repost in its entirety (http://leadstories.org/?p=2646).
SOURCE Alan Duke
Related Links
http://leadstories.org/?p=2646
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article